Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26401549 | 0.88 | MEN1 (0.31) | — | |
| SCHEMBL22928325 | 0.86 | PTPRC (0.32) | — | |
| SCHEMBL22928716 | 0.86 | ABL1 (0.38) | — | |
| SCHEMBL22928326 | 0.86 | ABL1 (0.38) | — | |
| SCHEMBL22928408 | 0.86 | PTAFR (0.33) | — | |
| SCHEMBL22928409 | 0.85 | L3MBTL1 (0.38) | — | |
| SCHEMBL22928311 | 0.82 | ABL1 (0.40) | — | |
| SCHEMBL22928322 | 0.81 | MEN1 (0.33) | — | |
| SCHEMBL26401419 | 0.78 | LTB4R2 (0.38) | — | |
| SCHEMBL22928353 | 0.78 | KCNA3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | C1S, DRD1, DRD3 | METAP2 2970/4885 |
| US-11780831-B2 | Compound, display panel and display apparatus | C1S, DRD1, DRD3 | METAP2 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.